Senators Kevin Cramer (R-ND) and John Curtis (R-UT) introduced the bipartisan Dietary Supplements Access Act, which would amend the Internal Revenue Code to designate over-the-counter dietary supplements as qualified medical expenses eligible for HSA, FSA, HRA, and Archer MSA reimbursement beginning in 2027. Individuals could allocate up to $250 per year toward supplements, while joint filers could claim up to $500, with a companion bill introduced in the House by Representatives LaHood, Boyle, Tenney, and Gottheimer. The Council for Responsible Nutrition, Natural Products Association, and Consumer Healthcare Products Association all endorsed the legislation as a long-sought, DSHEA-aligned policy win that would meaningfully expand consumer access to lawful supplements.

The FDA classified as a Class II recall a multi-state action affecting more than 4,000 units of Nephronex, an 8-ounce liquid multivitamin manufactured by Miami-based Llorens Pharmaceutical, after black particulate matter was detected during the bottling process. The contaminated lot (B2025, expiration 08/27) was distributed across 23 states and Puerto Rico between February and May 2026, and consumers are urged to return affected product for a refund. The episode reinforces continuing industry conversations about cGMP enforcement and the FDA’s ongoing role in policing supplement manufacturing under DSHEA’s quality framework.

A University of Surrey, John Innes Centre, and Quadram Institute meta-analysis published in Nutrition Reviews found that vitamin D2 supplementation can lower the body’s circulating vitamin D3, the more bioactive form linked to bone and immune support. Pooling 11 randomized controlled trials covering 655 adults, the authors said the finding warrants reconsideration of D3 as the preferred first-line supplementation choice. Product formulators and DSHEA-compliant marketers are likely to revisit claim language, sourcing decisions, and consumer education as the research filters into the public conversation.

CPG Radar’s analysis of 544 women’s supplement ingredients found creatine driving 253,000 monthly U.S. searches and 155.5% year-over-year growth, even as collagen, magnesium, and maca all contracted. The data reveals 76% of social media discussion surfaces around menopause and perimenopause, with brain function, energy, and sleep ranking above strength and muscle as expected outcomes. The piece underscores how DSHEA’s structure-function claims framework continues to shape category positioning as suppliers race to substantiate cognitive and longevity claims for a fast-growing buyer demographic.

The Dietary Supplements Access Act would let Americans use HSAs and FSAs for the lawful supplements they already rely on. Contact your Senators and Representatives today and ask them to cosponsor this bipartisan legislation in support of DSHEA-aligned consumer choice.

NutraIngredients’ monthly roundup highlights new product launches from GHOST, Vimergy, Nature’s Bounty, Maeva, INSTYTUTUM, Solaray, O Positiv, and LYMA, with energy, portability, skin, and longevity headlining the month. INSTYTUTUM’s NMN + Resveratrol launch and Maeva’s GLP-1 companion shake reflect two of the most-watched ingredient stories in the post-NMN-reversal supplement market. The launches collectively illustrate how DSHEA’s broad ingredient permissions continue to fuel rapid category innovation across need states.

Probiota Americas 2026 kicks off June 8 in Vancouver with a Day 1 program focused on market dynamics, regulatory shifts, and the emerging role of microbiome modulators in mitigating PFAS, microplastics, and PCB exposure. Speakers will spotlight FDA proposals to close self-affirmed GRAS pathways alongside tariff pressure and state-level supplement restrictions reshaping the operating environment. The Pioneers showcase will profile ClostraBio, Holobiome, and Kioga as probiotic and postbiotic categories continue to expand under DSHEA’s NDI framework.

Choline supplier Balchem unveiled an influencer-driven consumer education strategy aimed at building category awareness around choline’s role in cognitive development, prenatal health, and liver function. The campaign reflects a broader supplement industry pivot toward authority-signaled, science-anchored social content, an approach that echoes the same authority-driven purchase behavior described in this week’s creatine data. Industry observers say the model offers a DSHEA-compliant path to consumer education that respects the disease-claim guardrails the FDA continues to enforce.

Magtein, a branded form of magnesium L-threonate from AIDP, won the NutraIngredients Award for brain health research innovation, recognizing more than a decade of clinical work tying the ingredient to cognitive function and synaptic density. The honor lands as Magtein gained UK Food Standards Agency novel food clearance, a credential that supports global label claims for U.S. DSHEA-compliant brands. The recognition reinforces the supplement industry’s pivot toward cognition and healthy aging as core category drivers.

NutraIngredients’ 2026 Awards entries pointed to microbiome science, longevity ingredients, and women’s health formulations as the year’s most active innovation pillars. The submission patterns echo broader DSHEA-regulated industry trends, including a sharp uptick in NDI activity for novel actives and stronger investment in clinical substantiation. Editors noted the awards reflect a maturing market in which evidence and supply chain transparency increasingly determine commercial success.

© 2026 DSHEA Preservation Alliance. All rights reserved.

Protecting Lawful Supplements. Preserving Scientific Integrity.

Powered by PICXM

Unsubscribe
 | 
Update Preferences